NPI: 1831674654 · MURRAY, KY 42071 · Family Medicine Physician · NPI assigned 09/27/2018
Authorized official RAGER, REBECCA controls 20+ related entities in our dataset. Read more
| Authorized Official | RAGER, REBECCA (DIRECTOR REVENUE CYCLE) |
| NPI Enumeration Date | 09/27/2018 |
Other providers sharing the same authorized official: RAGER, REBECCA
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 30,194 | $520K |
| 2021 | 89,816 | $916K |
| 2022 | 140,231 | $1.11M |
| 2023 | 173,485 | $1.14M |
| 2024 | 69,295 | $685K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35,869 | 29,935 | $1.44M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35,856 | 29,009 | $1.04M |
| 87428 | 7,072 | 6,155 | $372K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,283 | 3,008 | $160K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,802 | 3,462 | $124K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3,495 | 2,989 | $111K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,380 | 3,987 | $110K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,579 | 1,410 | $106K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,386 | 1,286 | $98K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,376 | 1,143 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,846 | 12,052 | $75K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 913 | 858 | $75K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,199 | 2,493 | $64K |
| 80061 | Lipid panel | 4,578 | 3,949 | $40K |
| 99215 | Prolong outpt/office vis | 632 | 530 | $35K |
| 87430 | 2,578 | 2,383 | $35K | |
| 90461 | 1,165 | 1,027 | $31K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 3,110 | 495 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,490 | 1,944 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,659 | 3,982 | $26K |
| 80053 | Comprehensive metabolic panel | 3,060 | 2,592 | $18K |
| 90670 | 388 | 352 | $18K | |
| 36415 | Collection of venous blood by venipuncture | 17,561 | 14,893 | $17K |
| 80076 | 2,714 | 2,352 | $16K | |
| 81001 | 6,874 | 6,084 | $16K | |
| 90671 | 171 | 152 | $15K | |
| 87634 | 253 | 235 | $15K | |
| 92551 | 1,192 | 1,109 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 496 | 464 | $12K |
| 99441 | 502 | 406 | $11K | |
| 99442 | 299 | 227 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,926 | 1,610 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 521 | 403 | $10K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 15 | 12 | $9K |
| 83655 | 749 | 692 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | 796 | 659 | $8K |
| 96127 | 2,087 | 1,486 | $7K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 109 | 96 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | 251 | 181 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | 194 | 128 | $5K |
| 90619 | 106 | 103 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 512 | 464 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 242 | 233 | $5K |
| 87807 | 331 | 302 | $4K | |
| 99223 | Prolong inpt eval add15 m | 86 | 65 | $3K |
| 97802 | 524 | 472 | $3K | |
| 90698 | 280 | 250 | $3K | |
| 90686 | 289 | 277 | $3K | |
| 99349 | 189 | 115 | $3K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 31 | 27 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 30 | 25 | $2K |
| 96160 | 626 | 606 | $2K | |
| 99188 | 148 | 125 | $2K | |
| 90710 | 46 | 45 | $2K | |
| 59430 | 31 | 26 | $2K | |
| 93000 | 78 | 70 | $2K | |
| 90680 | 52 | 46 | $1K | |
| 84439 | 226 | 193 | $1K | |
| 99384 | 18 | 14 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 115 | 77 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 88 | 81 | $1K |
| 90633 | 208 | 182 | $1K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1,298 | 717 | $1K |
| 99383 | 12 | 12 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 73 | 63 | $1K |
| 90715 | 145 | 137 | $1K | |
| 90734 | 182 | 174 | $948.75 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 43 | 42 | $833.35 |
| 90682 | 25 | 25 | $790.06 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 67 | 46 | $753.84 |
| 90696 | 46 | 44 | $722.92 | |
| 90697 | 113 | 106 | $649.54 | |
| 76830 | Ultrasound, transvaginal | 16 | 16 | $623.45 |
| 99219 | 14 | 12 | $602.43 | |
| 0071A | 16 | 15 | $569.60 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 242 | 199 | $568.76 |
| 99217 | 18 | 16 | $486.31 | |
| 94760 | 973 | 865 | $452.30 | |
| 99350 | Prolong home eval add 15m | 25 | 12 | $436.79 |
| 90744 | 158 | 144 | $360.57 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 20 | 12 | $300.01 |
| 90677 | 30 | 30 | $283.72 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 55 | 14 | $233.53 |
| 90651 | 42 | 37 | $216.36 | |
| 90681 | 63 | 54 | $203.70 | |
| 84703 | 31 | 26 | $188.45 | |
| 96161 | 71 | 53 | $158.73 | |
| 85651 | 42 | 37 | $157.56 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 17 | 13 | $148.00 |
| 36416 | 648 | 562 | $144.48 | |
| 82950 | 29 | 26 | $114.50 | |
| 81003 | 133 | 108 | $110.20 | |
| 87210 | 22 | 12 | $58.20 | |
| 99072 | 2,737 | 2,239 | $50.00 | |
| 99305 | 16 | 13 | $48.80 | |
| 3074F | 28,864 | 25,394 | $43.57 | |
| 1125F | 15,671 | 13,317 | $39.56 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 137 | 108 | $37.58 |
| 3078F | 25,184 | 22,225 | $36.34 | |
| 1126F | 12,846 | 11,062 | $30.56 | |
| 3008F | 47,971 | 41,484 | $29.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 | 13 | $27.30 |
| 3079F | 10,476 | 9,304 | $24.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 73 | 54 | $14.12 |
| 3075F | 4,790 | 4,301 | $11.71 | |
| 3077F | 880 | 759 | $2.46 | |
| 1160F | 49,569 | 42,045 | $1.86 | |
| 1159F | 45,876 | 39,400 | $1.80 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 651 | 482 | $1.16 |
| 3080F | 355 | 306 | $1.00 | |
| 3044F | 119 | 105 | $0.13 | |
| 99491 | Ccm add 20min | 14 | 14 | $0.12 |
| 90672 | 104 | 100 | $0.04 | |
| 99499 | 625 | 537 | $0.04 | |
| 1034F | 9,349 | 8,132 | $0.04 | |
| 90685 | 46 | 46 | $0.02 | |
| 90647 | 16 | 16 | $0.02 | |
| 1036F | 28,771 | 23,206 | $0.01 | |
| 3725F | 16,079 | 13,928 | $0.00 | |
| 0521F | 69 | 61 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 57 | 52 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 957 | 698 | $0.00 |
| 2028F | 48 | 43 | $0.00 | |
| 3288F | 37 | 26 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 21 | 14 | $0.00 |
| 99497 | 21 | 14 | $0.00 | |
| 1124F | 56 | 34 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 25 | 25 | $0.00 |
| 888888 | 56 | 53 | $0.00 | |
| 1090F | 22 | 14 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 15 | 12 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 12,052 | 10,434 | $0.00 |
| 1000F | 844 | 767 | $0.00 | |
| 1035F | 137 | 119 | $0.00 | |
| 99000 | 1,999 | 1,684 | $0.00 | |
| 3048F | 636 | 611 | $0.00 | |
| 1170F | 77 | 48 | $0.00 | |
| 3049F | 17 | 14 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 20 | 13 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 58 | 40 | $0.00 |
| 0503F | 96 | 85 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 15 | 12 | $0.00 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 28 | 16 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 41 | 30 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 15 | 13 | $0.00 |
| 1101F | 17 | 12 | $0.00 |